Working… Menu
Trial record 86 of 440 for:    colon cancer AND Capecitabine

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (SALTO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01918852
Recruitment Status : Completed
First Posted : August 8, 2013
Last Update Posted : March 14, 2018
Nordic Pharma SAS
Information provided by (Responsible Party):
Dutch Colorectal Cancer Group